Tuesday 21 May, 2024 10:14 AM
Site map | Locate Us | Login
   Glenmark Pharma to commercialize BeiGene's oncology medicines in India    Energy shares gain    Capital Goods stocks edge higher    Metal shares gain    Parag Milk Foods Ltd Slips 9.28%    Vedanta Ltd Spurts 1.74%    Trident slides as Q4 PAT slumps 56% YoY; board OKs Rs 500-cr via NCDs    Solara Active Pharma?s Andhra Pradesh facility clears USFDA inspection    Phoenix Mills Q4 PAT climbs 32% YoY to Rs 388 cr    Trident Q4 PAT slumps 56% YoY; board OKs Rs 500-cr via NCDs    India Cements Q4 net loss narrows to Rs 50.06 cr    Parag Milk posts 56% YoY fall in Q4 PAT; EBITDA margin at 5.6%    Ujjivan SFB Q4 PAT rises 6% YoY; NII climbs 27% YoY to Rs 934 crore    Rainbow Medicare Q4 PAT slides to Rs 51 cr; ARPOB at Rs 54,185    Lupin?s USA facility gets 6 USFDA observations 
Saravan Stocks
       
Hot Pursuit
Scrips, which has significant changes during the market hours.
KFin Tech hits record high after Q4 PAT jumps 30% YoY
30-Apr-24   13:54 Hrs IST

Revenue from operation increased 24.68% year on year (YoY) to Rs 228.34 crore in the quarter ended 31 March 2024.

Profit before tax stood at Rs 94.37 crore in the quarter ended 31 March 2024, up 24.08% as against Rs 76.06 crore recorded in Q4 FY23.

During the quarter, EBITDA stood at Rs 104.6 crore, registering a growth of 24.8% as against Rs 83.83 crore recorded in Q4 FY23. EBITDA margin rose by 3 basis points YoY to 45.8% in Q4 FY24.

On the segmental front, revenue from domestic mutual fund investor solutions stood at Rs 161.41 crore (up 27.27% YoY), issuer solution stood at Rs 31.50 crore (up 14.15% YoY), international and other investor solutions was at Rs 27.25 crore (up 46.98% YoY) during the quarter.

On the other hand, global business services revenue declined 19.64% YoY to Rs 8.18 crore during the period under review.

Sreekanth Nadella, managing director and CEO, KFin Technologies said, ?We are delighted to announce another quarter and a full year of strong performance marked by consistent growth and enhanced profitability across our diverse business verticals. The year witnessed a notable uptick in our new client wins and international market engagements, underpinned by a swelling pipeline of deals.

This bodes well for our sustained growth trajectory and reaffirms our commitment to become a global fund administrator to service the burgeoning landscape of asset management industry, both in India and globally.?

Further, the board has recommended a final dividend of Rs 5.75 per share for the financial year ended March 2024.

On full year basis, the company's consolidated net profit increased 25.7% to Rs 246.05 crore on 16.32% rise in revenue from operations to Rs 837.53 crore in FY24 over FY23.

KFin Technologies is engaged in providing service of registrar to the public issue of securities, registrar to the securities transfers, and back office operations to mutual fund houses and data processing activities.

The counter hit an all time high of Rs 763.40 on the BSE.

Powered by Capital Market - Live News

   Attention Investors : Prevent Unauthorized Transactions in your demat account --> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from CDSL on the same day........issued in the interest of investors.
   Attention Investors : Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers / Depository Participant. Receive information of your transactions directly from Exchange / Depositories on your mobile / email at the end of the day .... Issued in the interest of Investors.
   Attention Investors : KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
   Attention Investors : No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
Email ID: info@ssplwealth.com       Customers grievances : grievances@ssplwealth.com     Compliance officer : Mr.R Udayakumar , compliance@ssplwealth.com,  Mobile No: 7305522205
Hit Count : 32735126
SEBI Regn.Nos : NSE/BSE-INZ000192638 | CDSL : IN-DP-262-2016
Member IDs : NSE : 11221 | BSE : 6292 | CDSL : 12045000 | MCX : 56990 | AMFI Regn.No : 2662
Designed , Developed & Content provided by CMOTS INFOTECH.(ISO 9001:2015 certified) © Copyright 2011 All Rights Reserved. SSPL WEALTH Pvt. Ltd